The effect of intravenous patient-controlled analgesia with esketamine combined with pulsed radiofrequency therapy on pain, anxiety, and depression in patients with postherpetic neuralgia: A Retrospective Study

Effects of intravenous patient-controlled analgesia with esketamine combined with radiofrequency pulse therapy on pain and depression of herpes zoster sequelae

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069263

Enrollment

Unknown

Registered

2023-03-10

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia (PHN)

Interventions

E group:No intervention

S group:No intervention

Eligibility

Sex/Gender

All

Age

30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria for herpes zoster in the Chinese Expert Consensus and the diagnostic criteria for PHN in the Chinese Expert Consensus on the Diagnosis and Treatment of neuralgia after herpes zoster. 2. Pain visual analogue scale (VAS) score > 4.

Exclusion criteria

Exclusion criteria: 1. There is severe organ insufficiency. 2. Have mental disorder or abnormal thinking ability and expression ability. 3. Locally infected. 4. Blood diseases or coagulation disorders. 5. Allergy to the drugs used in this study.

Design outcomes

Primary

Measure	Time frame
Numerical Rating Scale;Patient Health Questionnaire-9;Generalized Anxiexy Disorde-7;	—

Secondary

Measure	Time frame
Brief Pain Inventory;	—

Countries

China

Contacts

Public ContactQiu Ling

Affiliated Hospital of Southwest Medical University

1575327262@qq.com+86 187 8306 8433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026